![]()
|
|
||||||||
(Received for publication, January 29, 1996, and in revised form, June 14, 1996)
From the Division of Hemopoiesis, Institute of Hematology, and the
Department of Hematology, Jichi Medical School, Tochigi 329-04, Japan,
§ Katsuta Research Laboratory, Hitachi Koki Co., Ltd.,
Ibaraki 312, Japan, and ¶ Tsukuba Research Institute, Banyu
Pharmaceutical Co. Ltd., Ibaraki 300-33, Japan
Apoptosis has recently been hypothesized to be
the result of aberrant cell cycle control. In this study, we have
investigated the role of cell cycle-regulatory elements in Fas-induced
apoptosis of hematopoietic cells. When HL-60 cells were treated with
anti-Fas antibody, rapid activation of growth-associated histone H1
kinase was observed without any change in cell cycle distribution. This
was accompanied by the increase in cdc2 mRNA expression
and Cdc2 kinase activity. Up-regulation of cdc2 mRNA
was similarly induced in BCL-2-overexpressing HL-60 subline by anti-Fas
treatment independently of the appearance of apoptotic phenotypes.
Fas-induced apoptosis was completely inhibited by butyrolactone I, a
specific inhibitor of Cdc2 kinase. Moreover, the same phenomenon was
observed during Fas-induced but not spontaneous apoptosis of
postmitotic granulocytes. Finally, we have found that ``Fas-responsive
element'' was located between nucleotides
Volume 271, Number 45,
Issue of November 8, 1996
pp. 28469-28477
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
730 and
552 of the
cdc2 promoter and was responsive for transcriptional
activation of the cdc2 gene during Fas-induced apoptosis.
These results indicate that aberrant activation of Cdc2 is associated
with Fas-induced apoptosis of hematopoietic cells, and that the
mechanism of cdc2 transcription during Fas-induced
apoptosis is different from that in normal cell cycle control.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. Yue, E. Gershburg, and J. S. Pagano Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter J. Virol., May 1, 2005; 79(9): 5880 - 5885. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yue, M. G. Davenport, J. Shackelford, and J. S. Pagano Mitosis-Specific Hyperphosphorylation of Epstein-Barr Virus Nuclear Antigen 2 Suppresses Its Function J. Virol., April 1, 2004; 78(7): 3542 - 3552. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, J. Yang, S. K. Roy, S. Tininini, J. Hu, J. F. Bromberg, V. Poli, G. R. Stark, and D. V. Kalvakolanu The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3 PNAS, August 5, 2003; 100(16): 9342 - 9347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Footitt, M. Ingouff, D. Clapham, and S. von Arnold Expression of the viviparous 1 (Pavp1) and p34cdc2 protein kinase (cdc2Pa) genes during somatic embryogenesis in Norway spruce (Picea abies [L.] Karst) J. Exp. Bot., July 1, 2003; 54(388): 1711 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vondrácek, M. A. Sheard, P. Krejcí, K. Minksová, J. Hofmanová, and A. Kozubík Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells J. Leukoc. Biol., May 1, 2001; 69(5): 794 - 802. [Abstract] [Full Text] |
||||
![]() |
K. Suzuki, T. Hasegawa, C. Sakamoto, Y.-M. Zhou, F. Hato, M. Hino, N. Tatsumi, and S. Kitagawa Cleavage of Mitogen-Activated Protein Kinases in Human Neutrophils Undergoing Apoptosis: Role in Decreased Responsiveness to Inflammatory Cytokines J. Immunol., January 15, 2001; 166(2): 1185 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Razandi, A. Pedram, and E. R. Levin Plasma Membrane Estrogen Receptors Signal to Antiapoptosis in Breast Cancer Mol. Endocrinol., September 1, 2000; 14(9): 1434 - 1447. [Abstract] [Full Text] |
||||
![]() |
L. A. Porter, G. Singh, and J. M. Lee Abundance of cyclin B1 regulates gamma -radiation-induced apoptosis Blood, April 15, 2000; 95(8): 2645 - 2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kikuchi, Y. Furukawa, N. Kubo, A. Tokura, N. Hayashi, M. Nakamura, M. Matsuda, and I. Sakurabayashi Induction of Ubiquitin-Conjugating Enzyme by Aggregated Low Density Lipoprotein in Human Macrophages and Its Implications for Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Banerjee, A. P. Weston, M. N. Zoubine, D. R. Campbell, and R. Cherian Expression of Cdc2 and Cyclin B1 in Helicobacter pylori-Associated Gastric MALT and MALT Lymphoma : Relationship to Cell Death, Proliferation, and Transformation Am. J. Pathol., January 1, 2000; 156(1): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yun, H.-D. Chae, H. E. Choy, J. Chung, H.-S. Yoo, M.-H. Han, and D. Y. Shin p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor J. Biol. Chem., October 15, 1999; 274(42): 29677 - 29682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Laouar, D. Glesne, and E. Huberman Involvement of Protein Kinase C-beta and Ceramide in Tumor Necrosis Factor-alpha -induced but Not Fas-induced Apoptosis of Human Myeloid Leukemia Cells J. Biol. Chem., August 13, 1999; 274(33): 23526 - 23534. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scaffidi, I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer, and M. E. Peter Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells J. Biol. Chem., August 6, 1999; 274(32): 22532 - 22538. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujita, Y. Furukawa, N. Itabashi, Y. Tsuboi, M. Matsuda, K. Okada, and T. Saito Failure of cdc2 promoter activation and G2/M transition by ANG II and AVP in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H515 - H523. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Wang, D. M. Popp, H.-S. Wang, M. Saitoh, J. G. Mural, D. C. Henley, H. Ichijo, and J. Wimalasena Microtubule Dysfunction Induced by Paclitaxel Initiates Apoptosis through Both c-Jun N-terminal Kinase (JNK)-dependent and -Independent Pathways in Ovarian Cancer Cells J. Biol. Chem., March 19, 1999; 274(12): 8208 - 8216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Hendzel, W. K. Nishioka, Y. Raymond, C. D. Allis, D. P. Bazett-Jones, and J. P. H. Th'ng Chromatin Condensation Is Not Associated with Apoptosis J. Biol. Chem., September 18, 1998; 273(38): 24470 - 24478. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Duband-Goulet, J. Courvalin, and B Buendia LBR, a chromatin and lamin binding protein from the inner nuclear membrane, is proteolyzed at late stages of apoptosis J. Cell Sci., January 5, 1998; 111(10): 1441 - 1451. [Abstract] [PDF] |
||||
![]() |
M. C. Heinrich, M. E. Hoatlin, A. J. Zigler, K. V. Silvey, A. C. Bakke, W. W. Keeble, Y. Zhi, C. A. Reifsteck, M. Grompe, M. G. Brown, et al. DNA Cross-Linker-Induced G2/M Arrest in Group C Fanconi Anemia Lymphoblasts Reflects Normal Checkpoint Function Blood, January 1, 1998; 91(1): 275 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Furukawa, S. Iwase, J. Kikuchi, Y. Terui, M. Nakamura, H. Yamada, Y. Kano, and M. Matsuda Phosphorylation of Bcl-2 Protein by CDC2 Kinase during G2/M Phases and Its Role in Cell Cycle Regulation J. Biol. Chem., July 7, 2000; 275(28): 21661 - 21667. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |